...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Development of novel conformation-constrained cytotoxic derivatives of cheliensisin A by embedment of small heterocycles.
【24h】

Development of novel conformation-constrained cytotoxic derivatives of cheliensisin A by embedment of small heterocycles.

机译:通过嵌入小杂环化合物来开发新的构象限制的Cheliensisin A细胞毒性衍生物。

获取原文
获取原文并翻译 | 示例
           

摘要

Cheliensisin A is a natural styryl-lactone isolated from Goniothalamus cheliensis Hu in considerably large quantity with putative anticancer activities. However, its poor water solubility and chemical instability have precluded cheliensisin A as a potential drug candidate. To explore the strategy to overcome these problems, 21 novel derivatives of cheliensisin A with different substitutions at C-7 and C-8 positions were designed and synthesized. Inhibition of proliferation against five tumors cell lines indicates that eight new derivatives with embedment of oxazole or oxazoline exhibit improved cytotoxicity on SK-BR-3 and PANC-1, and compounds 2d and 2g show 5-8 folds higher potency than cisplatin. HPLC investigation of representative compounds indicates that oxazole and oxazoline analogs exhibit much improved chemical stability than their natural parent.
机译:Cheliensisin A是从Goniothalamus cheliensis Hu中分离的天然苯乙烯基内酯,具有大量推定的抗癌活性。但是,由于其水溶性差和化学不稳定性,使得cheliensisin A成为潜在的候选药物。为了探索解决这些问题的策略,设计并合成了21种在C-7和C-8位置具有不同取代基的cheliensisin A新型衍生物。针对五种肿瘤细胞系的增殖抑制表明,八种带有恶唑或恶唑啉嵌入物的新衍生物对SK-BR-3和PANC-1表现出改善的细胞毒性,化合物2d和2g的效力比顺铂高5-8倍。代表性化合物的HPLC研究表明,恶唑和恶唑啉类似物比其天然母体具有更高的化学稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号